Xiaoling Wu

Xiaoling Wu

Legend Biotech - / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4970694
person_outline Xiaoling Wu's MOST POPULAR ARTICLES
1-) Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1 … JG Berdeja, D Madduri, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ... The Lancet 398 (10297), 314-324, 2021 3542021
2-) Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies ME Thase, A Jonas, A Khan, CL Bowden, X Wu, RD McQuade, ... Journal of clinical psychopharmacology 28 (1), 13-20, 2008 3052008
3-) CARTITUDE-1: phase 1b/2 study of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy, in relapsed/refractory multiple myeloma D Madduri, JG Berdeja, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ... Blood 136, 22-25, 2020 1112020
4-) A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with …JC Bendell, RK Kelley, KC Shih, JA Grabowsky, E Bergsland, S Jones, ...Cancer 121 (19), 3481-3490, 2015892015
5-) Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.JG Berdeja, D Madduri, SZ Usmani, I Singh, E Zudaire, TM Yeh, AJ Allred, ...Journal of Clinical Oncology 38 (15_suppl), 8505-8505, 2020882020